Q2 2023 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2023-08-14 · accession 0001389933-23-000008
$365.7M
Reported value
73
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $47.0M | 12.9% | 565,000 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $24.1M | 6.59% | 612,975 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $20.9M | 5.72% | 13,680,554 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $15.9M | 4.35% | 251,521 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $13.7M | 3.75% | 512,285 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $13.0M | 3.56% | 102,500 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $12.1M | 3.30% | 135,212 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HOLDING INC | $11.9M | 3.24% | 206,748 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $11.3M | 3.08% | 479,820 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $10.9M | 2.97% | 332,734 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.8M | 2.95% | 280,538 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $10.1M | 2.77% | 384,870 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $9.4M | 2.58% | 450,873 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $9.1M | 2.50% | 42,173 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $8.7M | 2.37% | 67,552 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $8.5M | 2.32% | 180,306 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $7.0M | 1.92% | 74,615 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $6.2M | 1.69% | 125,529 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $6.1M | 1.66% | 507,100 | Common | SOLE |
| 23345J104 | — | DICE THERAPEUTICS INC | $5.9M | 1.62% | 127,585 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $5.6M | 1.52% | 556,695 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.5M | 1.50% | 611,032 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $5.0M | 1.37% | 496,416 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.8M | 1.30% | 293,655 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $4.7M | 1.29% | 1,222,358 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.6M | 1.25% | 225,717 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $4.1M | 1.13% | 1,307,407 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $4.0M | 1.10% | 519,384 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.0M | 1.10% | 569,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $3.8M | 1.05% | 638,938 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $3.8M | 1.04% | 357,784 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $3.6M | 0.99% | 4,000,000 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $3.4M | 0.94% | 94,700 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $3.1M | 0.85% | 122,200 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $3.0M | 0.83% | 332,103 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $2.7M | 0.75% | 257,653 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $2.7M | 0.74% | 110,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $2.7M | 0.73% | 810,845 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $2.2M | 0.61% | 930,394 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $2.1M | 0.59% | 52,675 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $1.9M | 0.53% | 797,054 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.9M | 0.52% | 47,661 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.6M | 0.45% | 1,111,049 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $1.6M | 0.44% | 172,308 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $1.5M | 0.42% | 940,582 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $1.5M | 0.41% | 361,084 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.3M | 0.36% | 1,009,013 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.3M | 0.36% | 98,560 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.2M | 0.31% | 504,681 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.1M | 0.31% | 242,779 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.1M | 0.30% | 350,373 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.1M | 0.29% | 127,653 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $996,002 | 0.27% | 76,852 | Common | SOLE |
| 86877M209 | — | SURFACE ONCOLOGY INC | $956,560 | 0.26% | 1,100,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $837,516 | 0.23% | 265,878 | Common | SOLE |
| 69945Q105 | — | PARDES BIOSCIENCES INC | $778,827 | 0.21% | 430,291 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $711,760 | 0.19% | 28,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $684,000 | 0.19% | 450,000 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $674,492 | 0.18% | 313,717 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $670,800 | 0.18% | 312,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $505,023 | 0.14% | 21,113 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $493,650 | 0.13% | 3,000 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $371,685 | 0.10% | 116,882 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $344,894 | 0.09% | 192,678 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $337,853 | 0.09% | 187,696 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $324,734 | 0.09% | 351,064 | Common | SOLE |
| 58490H107 | MDNAF | MEDICENNA THERAPEUTICS CORP | $317,922 | 0.09% | 660,000 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $282,800 | 0.08% | 8,000 | Common | SOLE |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $242,942 | 0.07% | 80,179 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $233,930 | 0.06% | 205,202 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $197,400 | 0.05% | 140,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $181,250 | 0.05% | 125,000 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $173,250 | 0.05% | 15,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.